Arcutis Biotherapeutics Stock Options Expiring on 17th of January

ARQT Stock  USD 16.77  0.17  1.02%   

Arcutis Biotherapeutics Market Cap Over Time

   Market Cap   
       Timeline  

Arcutis Total Stockholder Equity

Total Stockholder Equity

127.89 Million

At this time, Arcutis Biotherapeutics' Total Stockholder Equity is comparatively stable compared to the past year.

Arcutis Biotherapeutics Corporate Management

JD EsqGeneral VPProfile
Patricia TurneyVP OperationsProfile
Todd EdwardsExecutive OfficerProfile
Eric McIntyreHead RelationsProfile
Ayisha JeterHead AccessProfile
David OsborneChief OfficerProfile
Bethany DudekChief OfficerProfile

Additional Tools for Arcutis Stock Analysis

When running Arcutis Biotherapeutics' price analysis, check to measure Arcutis Biotherapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Arcutis Biotherapeutics is operating at the current time. Most of Arcutis Biotherapeutics' value examination focuses on studying past and present price action to predict the probability of Arcutis Biotherapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Arcutis Biotherapeutics' price. Additionally, you may evaluate how the addition of Arcutis Biotherapeutics to your portfolios can decrease your overall portfolio volatility.